Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 66, pseudogene (RNU6-66P)
- Target
- RNU6-66P
- Molecular classification
- Pseudogene, Small nuclear RNA (snRNA) pseudogene: Not a protein-coding gene, but a non-coding RNA derived from snRNA.
01
Overview
RNA, U6 small nuclear 66, pseudogene (RNU6-66P) is a genomic element classified as a *pseudogene* of the U6 small nuclear RNA family. U6 snRNAs are highly conserved small non-coding RNAs that provide critical structural and catalytic roles in the major spliceosome, the cellular machinery responsible for pre-mRNA splicing in eukaryotes[1][3]. Pseudogenes such as RNU6-66P arise via duplication or retrotransposition events and are typically non-functional; they do not produce mature, functional RNA molecules and lack biological activity, nor are they considered targets for therapeutic intervention or biomarkers for disease[3][4].
- Other names
- RNU6-66RNU6-66P
02
Mechanism of action
Not applicable; pseudogenes do not encode functional molecules and do not have drug-targeted mechanisms.
03
Biological functions
Pseudogenes generally lack biological function; functional U6 snRNA (not the pseudogene) plays a critical role in premRNA splicing, but the pseudogene does not participate in this process[1][3].
04
Disease associations
None known for this pseudogene.Functional U6 snRNA is involved in the spliceosome; its dysregulation may contribute to disease, but this does not apply to pseudogenes[1][3].
05
Safety considerations
Not applicable.
06
Interacting drugs
None known; pseudogenes are not drug targets.
07
Biomarkers
Not used as a biomarker for patient selection or efficacy monitoring.Functional U6 snRNA (e.g., RNU6-2) is sometimes used as a reference gene for normalization in qPCR studies[2], but pseudogenes are not.
Beyond the preview
Go deeper on RNA, U6 small nuclear 66, pseudogene (RNU6-66P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 66, pseudogene (RNU6-66P).